William Michael Rosellini
Founder at Cytoimmune Therapeutics, Inc.
William Michael Rosellini active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cytoimmune Therapeutics, Inc.
 Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Founder | 2019-05-31 | - |
| Public Communications Contact | 2019-05-31 | - | |
| President | 2019-05-31 | - |
Career history of William Michael Rosellini
Former positions of William Michael Rosellini
| Companies | Position | Start | End |
|---|---|---|---|
| NEXEON MEDSYSTEMS INC | Director/Board Member | 2015-12-06 | - |
| Chief Executive Officer | 2015-12-06 | 2020-10-21 | |
| Chairman | - | 2020-10-21 | |
| President | 2015-12-06 | 2016-11-30 | |
Rosellini Scientific LLC
 Rosellini Scientific LLC Medical SpecialtiesHealth Technology Rosellini Scientific LLC develops medical rehabilitation devices. The private company is based in Lexington, KY and has subsidiaries in the United States. The company was founded by William Michael Rosellini. | Chairman | 2004-12-31 | 2016-11-30 |
| Founder | 2004-12-31 | 2016-11-30 | |
| MARATHON DIGITAL HOLDINGS, INC. | Director/Board Member | 2012-12-31 | 2016-08-31 |
| Independent Dir/Board Member | 2012-12-31 | 2016-08-31 | |
| The University of Texas at Dallas | Corporate Officer/Principal | 2013-04-30 | 2015-07-31 |
Sarif Biomedical LLC
 Sarif Biomedical LLC Medical SpecialtiesHealth Technology Part of Marathon Digital Holdings, Inc., Sarif Biomedical LLC is a company that manufactures surgery related equipment. The company is based in Tool, TX. Sarif Biomedical was acquired by Marathon Digital Holdings, Inc. on May 02, 2014 for $0.55 million. | Chief Executive Officer | 2013-05-31 | 2014-07-31 |
| Lexington Technology Group, Inc. | Chief Executive Officer | 2012-05-31 | 2013-11-30 |
Nuviant Medical, Inc.
 Nuviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Nuviant Medical, Inc. provides janitorial services. The firm offers commercial and healthcare cleaning services. The company was founded in 1997 and is headquartered in Dallas, TX. | Director/Board Member | 2014-11-30 | - |
| Chief Executive Officer | 2014-11-30 | - | |
| Founder | 2014-11-30 | - | |
| Texas Onsite Dental | Founder | - | - |
| President | - | - | |
| ░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of William Michael Rosellini
| University of Southern California | Graduate Degree |
| Rutgers State University of New Jersey | Graduate Degree |
| The University of Texas at Austin | Doctorate Degree |
| University of Dallas | Undergraduate Degree |
| Maurice A. Deane School of Law at Hofstra University | Graduate Degree |
Statistics
International
| United States | 14 |
| France | 2 |
| 2 |
Operational
| Founder | 5 |
| President | 4 |
| Graduate Degree | 4 |
Sectoral
| Consumer Services | 7 |
| Health Technology | 6 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| MARATHON DIGITAL HOLDINGS, INC. | Technology Services |
| NEXEON MEDSYSTEMS INC | Health Technology |
| Private companies | 7 |
|---|---|
Nuviant Medical, Inc.
Nuviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Nuviant Medical, Inc. provides janitorial services. The firm offers commercial and healthcare cleaning services. The company was founded in 1997 and is headquartered in Dallas, TX. | Commercial Services |
MicroTransponder, Inc.
 MicroTransponder, Inc. Medical SpecialtiesHealth Technology MicroTransponder, Inc. develops wireless neurostimulation system for the treatment of chronic pain and other neurological indications. It is a medical device company spun out from the University of Texas at Dallas. The firm has an team of neuroengineers collaborating with academics to develop wireless solutions to treat neurological diseases. The company was founded by Lawrence James Cauller, Thomas James Curnes II and William Michael Rosellini in June 2009 and is headquartered in Austin, TX. | Health Technology |
| Texas Onsite Dental | |
| Lexington Technology Group, Inc. | Finance |
Rosellini Scientific LLC
Rosellini Scientific LLC Medical SpecialtiesHealth Technology Rosellini Scientific LLC develops medical rehabilitation devices. The private company is based in Lexington, KY and has subsidiaries in the United States. The company was founded by William Michael Rosellini. | Health Technology |
Sarif Biomedical LLC
Sarif Biomedical LLC Medical SpecialtiesHealth Technology Part of Marathon Digital Holdings, Inc., Sarif Biomedical LLC is a company that manufactures surgery related equipment. The company is based in Tool, TX. Sarif Biomedical was acquired by Marathon Digital Holdings, Inc. on May 02, 2014 for $0.55 million. | Health Technology |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Health Technology |
